NDC50242-0137-01: TOCILIZUMAB INJECTION.
The TOCILIZUMAB INJECTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: TOCILIZUMAB INJECTION, 400MG/20ML, ONE VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-687-8205, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | TOCILIZUMAB INJECTION, 400MG/20ML, ONE VIAL |
| NSN | 6505-01-687-8205 |
| SPECIAL FEATURES | ACTEMRA (TOCILIZUMAB) IS AN INTERLEUKIN-6 (IL-6) RECEPTOR ANTAGONIST INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, GIANT CELL ARTERITIS, POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, SYSTEMIC JUVENILE ARTHRITIS, AND CYTOKINE RELEASE SYNDROME (CRS); INTRAVENOUS INFUSION ONLY AFTER DILUTION; 400MG/20ML; SINGLE-USE VIAL; DISCARD UNUSED PORTION; NO PRESERVATIVE; ACTEMRA (TOCILIZUMAB) INJECTION IS A PRESERVATIVE-FREE,STERILE CLEAR, COLORLESS TO PALE YELLOW SOLUTION. STORE AT 2 C TO 8 C (36 F TO 46 F). DO NOT FREEZE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | TOCILIZUMAB INJECTION, 400MG/20ML, ONE VIAL |